NCT07169344View on ClinicalTrials.gov

Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

November 1, 2028

Study Completion Date

November 1, 2035

Conditions
Soft Tissue Sarcoma (Excluding GIST)Soft Tissue Sarcoma AdultSoft Tissue Sarcoma of the Trunk and ExtremitiesSynovial SarcomasLeiomyosarcomaUndifferentiated Pleomorphic Sarcoma (UPS)Myxofibrosarcoma (MFS)LiposarcomaPleomorphic Rhabdomyosarcoma
Interventions
RADIATION

preoperative

The radiotherapy will be delivered 2.85 Gy x 15 for both x-ray or proton radiotherapy. A comparative doseplan will decide if the patient will receive proton og x-ray radiotherapy.

OTHER

Quality of life

Questionnaire

OTHER

Functional outcome

Questionnaire

Trial Locations (4)

Unknown

Haukeland University Hospital, Bergen

Oslo University Hospital, Oslo

University Hospital of North Norway, Tromsø

St. Olavs University Hospital, Trondheim

All Listed Sponsors
collaborator

Haukeland University Hospital

OTHER

collaborator

University Hospital of Northern Norway, Tromsø, Norway

UNKNOWN

collaborator

St. Olavs Hospital

OTHER

lead

Oslo University Hospital

OTHER

NCT07169344 - Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma | Biotech Hunter | Biotech Hunter